Risedronate rapidly reduces the risk for nonvertebral fractures in women with postmenopausal osteopo...
Risedronate rapidly reduces the risk for nonvertebral fractures in women with postmenopausal osteoporosis
About this item
Full title
Author / Creator
Harrington, J T , Ste-Marie, L-G , Brandi, M L , Civitelli, R , Fardellone, P , Grauer, A , Barton, I and Boonen, S
Publisher
United States: Springer Nature B.V
Journal title
Language
English
Formats
Publication information
Publisher
United States: Springer Nature B.V
Subjects
More information
Scope and Contents
Contents
Prevention of nonvertebral fractures, which account for a substantial proportion of osteoporotic fractures, is an important goal of osteoporosis treatment. Risedronate, a pyridinyl bisphosphonate, significantly reduces clinical vertebral fracture incidence within 6 months. To determine the effect of risedronate on osteoporosis-related nonvertebral...
Alternative Titles
Full title
Risedronate rapidly reduces the risk for nonvertebral fractures in women with postmenopausal osteoporosis
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_80175787
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_80175787
Other Identifiers
ISSN
0171-967X
E-ISSN
1432-0827
DOI
10.1007/s00223-003-0042-4
